Utilization of a Population Pharmacokinetic Model to Improve a Busulfan Test-Dose Strategy in Allogeneic Hematopoietic Cell Transplant Recipients.

MLA

Dunlap, Tyler C., et al. “Utilization of a Population Pharmacokinetic Model to Improve a Busulfan Test-Dose Strategy in Allogeneic Hematopoietic Cell Transplant Recipients.” Journal of Clinical Pharmacology, vol. 63, no. 9, Sept. 2023, pp. 1026–35. EBSCOhost, https://doi.org/10.1002/jcph.2257.

APA

Dunlap, T. C., Weiner, D. L., Kemper, R. M., Kardouh, M., DeVane, S. C., Symonds, A., Shaw, J. R., Armistead, P. M., Ptachcinski, J. R., & Crona, D. J. (2023). Utilization of a Population Pharmacokinetic Model to Improve a Busulfan Test-Dose Strategy in Allogeneic Hematopoietic Cell Transplant Recipients. Journal of Clinical Pharmacology, 63(9), 1026–1035. https://doi.org/10.1002/jcph.2257

Chicago

Dunlap, Tyler C, Daniel L Weiner, Ryan M Kemper, Miramar Kardouh, Susanna C DeVane, Allison Symonds, J Ryan Shaw, Paul M Armistead, Jonathan R Ptachcinski, and Daniel J Crona. 2023. “Utilization of a Population Pharmacokinetic Model to Improve a Busulfan Test-Dose Strategy in Allogeneic Hematopoietic Cell Transplant Recipients.” Journal of Clinical Pharmacology 63 (9): 1026–35. doi:10.1002/jcph.2257.